Treatment of post-allogeneic stem cell transplant cytopenias with sequential doses of mesenchymal stromal cells: results of a multicenter Phase II trial

被引：0
|
作者：
Veiga, A. [1 ]
Redondo, A. [1 ]
Villaron, E. [1 ]
Lopez-Parra, M. [1 ]
Arratibel, N. [1 ]
Baile, M. [1 ]
Lopez-Villar, O. [1 ]
Cabrero, M. [1 ]
Perez, E. [1 ]
Lopez-Corral, L. [1 ]
Vazquez, L. [1 ]
Perez-Simon, J. A. [2 ]
Prosper, F. [3 ]
Caballero, M. D. [1 ]
Canizo, M. C. D. [1 ]
Sanchez-Guijo, F. [1 ]
机构：
[1] Hosp Univ Salamanca, IBSAL, Salamanca, Spain
[2] Hosp Virgen del Rocio, IBIS, Seville, Spain
[3] Clin Univ Navarra, Navarra, Spain
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O081
引用
收藏
页码：S58 / S59
页数：2
相关论文
共 50 条
  • [21] CLINICAL PRACTICE GUIDELINE FOR THE TREATMENT OF BK-VIRUS INDUCED HEMORRHAGIC CYSTITIS IN THE POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT SETTING
    Morrison, D.
    Kochuparambil, T.
    DeRemer, D.
    Kota, V
    Jillela, A.
    Awan, F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S329 - S329
  • [22] Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient
    Oza, Aabha
    Rettig, Michael P.
    Powell, Phil
    O'Brien, Kathryn
    Clifford, David B.
    Ritchey, Julie
    Gehrs, Leah
    Hollaway, Julia
    Major, Eugene
    Fehniger, Todd A.
    Miller, Christopher A.
    Soon-Shiong, Patrick
    Rock, Amy
    DiPersio, John F.
    BLOOD ADVANCES, 2020, 4 (11) : 2387 - 2391
  • [23] LEUKEMIC CELLS DEMONSTRATE GENE EXPRESSION PROFILES THAT MAY CONFER SURVIVAL ADVANTAGE IN THE POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT ENVIRONMENT
    Fountaine, Thomas
    Andolina, Jeffrey
    Hsu, Yu
    Rademacher, Brooks
    Bhattacharya, Soumyaroop
    Chu, ChinYi
    Mariani, Thomas
    Mullen, Craig
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S96 - S97
  • [24] Locally injected allogeneic bone marrow-derived mesenchymal stromal cells for the treatment of refractory proctitis: clinical results of a phase IIa trial
    Drs, L. Ouboter
    Barnhoorn, M.
    van Pel, M.
    Zwaginga, J. J.
    Hawinkels, L.
    Maljaars, J.
    Koning, F.
    Verspaget, H.
    van der Meulen-de de Jong, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S381 - S381
  • [25] Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
    Stewart, AK
    Chen, CI
    Howson-Jan, K
    White, D
    Roy, J
    Kovacs, MJ
    Shustik, C
    Sadura, A
    Shepherd, L
    Ding, K
    Meyer, RM
    Belch, AR
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8170 - 8176
  • [26] Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial
    Strojan, Primoz
    Plavc, Gaber
    Kokalj, Marko
    Mitrovic, Goran
    Blatnik, Olga
    Lezaic, Luka
    Socan, Aljaz
    Bavec, Aljosa
    Tesic, Natasa
    Hartman, Katrina
    Svajger, Urban
    RADIOLOGY AND ONCOLOGY, 2023, 57 (04) : 538 - 549
  • [27] High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial
    Ferreri, Andres J. M.
    Donadoni, Giovanni
    Cabras, Maria Giuseppina
    Patti, Caterina
    Mian, Michael
    Zambello, Renato
    Tarella, Corrado
    Di Nicola, Massimo
    D'Arco, Alfonso
    Doa, Gianluca
    Bruno-Ventre, Marta
    Foppoli, Marco
    Fanni, Alessandro
    Mule, Antonino
    Ciceri, Fabio
    Caligaris-Cappio, Federico
    BLOOD, 2014, 124 (21)
  • [28] HIGH DOSES OF ANTIMETABOLITES FOLLOWED BY HIGH-DOSE SEQUENTIAL CHEMOIMMUNOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH SYSTEMIC B-CELL LYMPHOMA AND SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: FINAL RESULTS OF A MULTICENTER PHASE II TRIAL
    Ferreri, A. J. M.
    Foppoli, M.
    Citterio, G.
    Cabras, M. G.
    Patti, C.
    Mian, M.
    Zambello, R.
    Tarella, C.
    Di Nicola, M.
    D'Arco, A. M.
    Doa, G.
    Bruno-Ventre, M.
    Sassone, M.
    Scarfo, L.
    Fanni, A.
    Mule, A.
    Calimeri, T.
    Ciceri, F.
    Caligaris-Cappio, F.
    HAEMATOLOGICA, 2015, 100 : 40 - 40
  • [29] cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem-cell transplantation in patients with severe aplastic anemia: multicenter phase II trial results
    Xiao, Y.
    Liu, Z.
    Yao, Z.
    Xiao, H.
    Li, Y.
    Wang, S.
    Zhang, Y.
    Liu, Q.
    Fan, Z.
    Wu, B.
    Nie, D.
    Jiang, Z.
    Li, L.
    Pang, Y.
    Zhang, H.
    Ouyang, L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S30 - S31
  • [30] Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
    Kristina Hölig
    Helmuth Schmidt
    Gero Hütter
    Michael Kramer
    Raphael Teipel
    Katharina Heidrich
    Kristin Zimmer
    Falk Heidenreich
    Matthias Blechschmidt
    Tigran Torosian
    Rainer Ordemann
    Frank Kroschinsky
    Elke Rücker-Braun
    Laszlo Gopsca
    Eva Maria Wagner-Drouet
    Uta Oelschlaegel
    Alexander H. Schmidt
    Martin Bornhäuser
    Gerhard Ehninger
    Johannes Schetelig
    Bone Marrow Transplantation, 2022, 57 : 143 - 143
12345